These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 3470578
1. In-vitro studies on phosphorylation and dephosphorylation of cytosine arabinoside in human leukemic cells. Muus P, Drenthe-Schonk A, Haanen C, Wessels H, Linssen P. Leuk Res; 1987; 11(4):319-25. PubMed ID: 3470578 [Abstract] [Full Text] [Related]
2. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters]. Schiller M, Hohenlöchter B, Schulze-Westhoff P, Zimmermann M, Ritter J, Jürgens H, Boos J. Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681 [Abstract] [Full Text] [Related]
3. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow. Tanaka M. Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741 [Abstract] [Full Text] [Related]
4. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Boos J, Hohenlöchter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jurgens H. Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376 [Abstract] [Full Text] [Related]
7. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells. Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Safah H, Graham G. Exp Hematol; 1991 Aug; 19(7):669-73. PubMed ID: 1893953 [Abstract] [Full Text] [Related]
10. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells. Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G. Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363 [Abstract] [Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T. Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573 [Abstract] [Full Text] [Related]
12. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole. Yang JL, White JC, Capizzi RL. Cancer Chemother Pharmacol; 1992 Apr; 29(3):236-40. PubMed ID: 1733557 [Abstract] [Full Text] [Related]
13. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ. Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322 [Abstract] [Full Text] [Related]
14. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W, Hug V, Keating MJ, Chubb S. Cancer Res; 1980 Mar 01; 40(3):588-91. PubMed ID: 6937239 [Abstract] [Full Text] [Related]
15. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia. Gandhi V, Xu YZ, Estey E. Clin Cancer Res; 1998 Jul 01; 4(7):1719-26. PubMed ID: 9676847 [Abstract] [Full Text] [Related]